Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment

Fig. 2

Receptor expression characteristics in treatment-naïve CHB patients. MFI for NKp44 (a), NKp46 (b), NKG2D (c), and NKp30 (d) on CD56+CD3− NK cells and the frequency for NKG2A+ cells (e) within CD56+CD3− NK cells in healthy controls (HC) and CHB patients (CHB)/CHB subgroups. Comparison between the HC group and total CHB group is shown on the left plots and comparisons between the HC group and different CHB subgroups that represent the different clinical phases are shown on the right plots. Horizontal bars represent the median value. CHB chronic hepatitis B, HC healthy control, IA immune active, IT immune tolerance, IC inactive CHB, and GZ grey zone

Back to article page